Disruptions in substrate availability, co-factor balance, or recycling processes—due to oxidative stress, metabolic disorders, or nutrient deficiencies—can impair eNOS activity and reduce NO bioavailability (Figure 5). This evidence concerns the gene NOS3 and Other metabolic disease.